Anthony J. Polverino

Anthony J. Polverino is a declared insider at 2 companies (senior executive); the most frequent names are Brainstorm Cell Therapeutics Inc. and Zymeworks Inc. We count 21 filings; the first trade dates from 1 February 2018 and the latest from 1 January 2025.

No open-market purchase appears, only 1 sale worth €31k. Besides market trades, the filings include 17 share grants and 3 option exercises.

Most recently, on 3 January 2025, the filings show a share grant in Brainstorm Cell Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.